您的购物车当前为空
别名 脲基琥珀酸, 氨基甲酰-DL-天(门)冬氨酸, Ureidosuccinic acid, N-Carbamoyl-DL-aspartic acid
N-Carbamoyl-DL-aspartic acid (Ureidosuccinic acid) 是核酸嘧啶的前体之一。

N-Carbamoyl-DL-aspartic acid (Ureidosuccinic acid) 是核酸嘧啶的前体之一。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 mg | ¥ 126 | In stock | |
| 100 mg | ¥ 169 | In stock | |
| 500 mg | ¥ 372 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 108 | In stock |
N-Carbamoyl-DL-aspartic acid 相关产品
| 产品描述 | N-Carbamoyl-DL-aspartic acid (Ureidosuccinic acid) is an intermediary product in pyrimidine biosynthesis. |
| 别名 | 脲基琥珀酸, 氨基甲酰-DL-天(门)冬氨酸, Ureidosuccinic acid, N-Carbamoyl-DL-aspartic acid |
| 分子量 | 176.13 |
| 分子式 | C5H8N2O5 |
| CAS No. | 923-37-5 |
| Smiles | NC(=O)NC(CC(O)=O)C(O)=O |
| 密度 | 1.596 g/cm3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (283.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (11.36 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容